Reuters logo
BRIEF-Itus says Cchek preliminary cancer patient efficacy study results
December 7, 2016 / 12:00 PM / a year ago

BRIEF-Itus says Cchek preliminary cancer patient efficacy study results

Dec 7 (Reuters) - Itus Corp -

* Itus Corp announces Cchek preliminary cancer patient efficacy study results

* Achieved sensitivity of 92 pct and specificity of 92 pct for 88 patient samples as per study results - SEC filing Source text - (bit.ly/2h2ij5l) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below